← Home / AXSOME THERAPEUTICS, INC. (AXSM)
Stock Analysis
AXSOME THERAPEUTICS, INC. (AXSM)
AXSM
AXSM · Healthcare • Biotech
221.02 -5.80%
Track AXSM in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when AXSM price is:
52W Range Position
78%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-07-31 15:43 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 231.98. Holding above 191.65 keeps the current thesis intact.
⚖️
✓
Fundamentals
Strong / Negative
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
191.65
↗
Break Above
Confirmation improves above resistance.
231.98
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 191.65
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
15
●
Material Agreement
MEDIUM
Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy
FDA sets PDUFA target action date of May 1, 2027 NEW YORK, July 15, 2026 (Globe Newswire) – Axsome Therapeutics, Inc.
8-K Filing • SEC EDGAR
JUN
9
●
Management / Board
MEDIUM
AXSM board and management update
The Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of Axsome Therapeutics, Inc.
8-K Filing • SEC EDGAR
JUN
3
●
Legal / Regulatory
HIGH
Axsome Therapeutics Announces Settlement Resolving All SUNOSI ® (solriamfetol) Patent Litigation
NEW YORK, June 3, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc.
8-K Filing • SEC EDGAR
What's Driving AXSM?
📈 Technical recovery is improving
Momentum is Neutral. Watch 231.98 for confirmation and 191.65 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 191.63 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
240.18
Invalidation
240.18
RSI(14)
39.8
◎
How to read this setup
The nearest decision zone is framed by support around 191.63 and resistance near 231.92. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
AXSM — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-30
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$12.1B
Company size
EV
$12.0B
Debt-adjusted value
P/S
17.0
Premium
P/B
221.0
Very high
EV/Sales
16.9
Premium
FCF Yield
-0.59%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Recovering
⚖
Balance Sheet
Pressured
💵 Revenue
191.20M
↗ Strong
📈 Net Income
-64.54M
↘ Negative
🧮 EPS (Basic)
-1.26
↘ Negative
AXSOME THERAPEUTICS, INC.
Healthcare • Biotech
Related Opportunities